Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Operating Expenses: 2009-2025

Historic Operating Expenses for Aytu Biopharma (AYTU) over the last 17 years, with Sep 2025 value amounting to $10.7 million.

  • Aytu Biopharma's Operating Expenses fell 17.23% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.4 million, marking a year-over-year increase of 3.58%. This contributed to the annual value of $53.7 million for FY2025, which is 5.95% up from last year.
  • Aytu Biopharma's Operating Expenses amounted to $10.7 million in Q3 2025, which was down 40.20% from $17.9 million recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Operating Expenses ranged from a high of $66.1 million in Q1 2022 and a low of $10.4 million during Q1 2025.
  • In the last 3 years, Aytu Biopharma's Operating Expenses had a median value of $12.9 million in 2024 and averaged $14.1 million.
  • Per our database at Business Quant, Aytu Biopharma's Operating Expenses spiked by 208.55% in 2021 and then plummeted by 67.78% in 2023.
  • Over the past 5 years, Aytu Biopharma's Operating Expenses (Quarterly) stood at $23.6 million in 2021, then grew by 2.41% to $24.2 million in 2022, then tumbled by 52.58% to $11.5 million in 2023, then increased by 8.94% to $12.5 million in 2024, then decreased by 17.23% to $10.7 million in 2025.
  • Its Operating Expenses was $10.7 million in Q3 2025, compared to $17.9 million in Q2 2025 and $10.4 million in Q1 2025.